MedPath

Evaluation of Comparative Efficacy of Vamana Karma (Therapeutic emesis) versus Virechana Karma (Therapeutic purgation) in the management of Subclinical Hypothyroidism

Not Applicable
Conditions
Health Condition 1: E038- Other specified hypothyroidismHealth Condition 2: E038- Other specified hypothyroidismHealth Condition 3: E02- Subclinical iodine-deficiency hypothyroidism
Registration Number
CTRI/2022/12/047833
Lead Sponsor
Dr Deepali Ramakant Sherekar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Subjects who are willing to give written informed consent.

2.TSH value 4.5 to 14.9 mU/L , T3 level <100ng/dL,T4 level <0.8ng/dL

3.Subjects of either gender between 20 to 50 years

4.Subjects who are fit (yogya) for Vamana Karma & Virechana Karma.

5. Subjects with Body mass index ranges from 18.5 up to 39.9 kg/m2.

6.Subjects of Madhyam Koshta,Madhyam Agnibala (samagni) will be included.

Exclusion Criteria

1.Subjects not fit for Vaman Karma and Virechan Karma.

2.Subjects suffering from congenital Hypothyroidism & Carcinoma of thyroid gland.

3.Subjects with Pitta predominant prakruti and Pitta disorders like (Amalpitta/parinamshoola) Ulcer,Hyperacidity etc

4.TSH value more or less than 4.5 to 14.9 mU/L range

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.correcting the values of Thyroid profile. <br/ ><br>2.Reducing weight with respect to BMI <br/ ><br>Timepoint: 0th day, 20th day,After 3 months <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Virechana karma is equially efficacious as Vamana karma in the management of Subclinical hypothyroidismTimepoint: 0th day ,3 months
© Copyright 2025. All Rights Reserved by MedPath